Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial.
Lancet Gastroenterol Hepatol
; 7(12): 1092-1102, 2022 12.
Article
in En
| MEDLINE
| ID: mdl-36183738
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hepatolenticular Degeneration
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Lancet Gastroenterol Hepatol
Year:
2022
Document type:
Article